Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 4:48 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
2,844 | $0 | 10,430 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-06 4:48 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
572 | $70.31 | 10,430 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:46 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 5:28 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
2,604 | $0 | 8,158 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 5:28 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
495 | $76.88 | 8,158 (Direct) |
View |
| 2023-06-26 Equity Swap |
2023-06-26 4:05 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
48,639 | $9.1 | 0 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:13 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-07 6:17 pm |
N/A 2033-04-05 |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2023-03-16 Tax Withholding |
2023-03-17 4:27 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
446 | $78.15 | 6,049 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:11 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
2,250 | $0 | 6,495 (Direct) |
View |
| 2022-12-16 Ownership |
2023-02-14 6:19 pm |
N/A N/A |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
43,785 | $0 | 48,639 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:23 pm |
N/A 2032-06-09 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 8:12 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
2,028 | $0 | 4,245 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 7:48 pm |
N/A 2032-03-09 |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 4:39 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
2,217 | $0 | 2,217 (Direct) |
View |
Ownership |
2021-05-19 4:19 pm |
N/A N/A |
HENRY SCHEIN INC | HSIC | Tuckson Reed Vaughn Director |
0 | $0 | 0 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 6:53 pm |
N/A 2031-03-10 |
CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 7:13 pm |
N/A 2031-02-18 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
45,000 | $0 | 45,000 (Direct) |
View |
Ownership |
2021-02-23 7:12 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
0 | $0 | 0 (Direct) |
View |